President Trump And Drug Pricing: Rhetorical Improvement But Uncertainty Remains

In his first address to Congress, President Trump didn’t drop drug pricing as a theme, but he also didn’t accuse the industry of 'getting away with murder.' For innovators, that’s at least a rhetorical improvement. Now the debate becomes what the US president means by prices that are 'artificially' high.

More from Legislation

More from Pink Sheet